Yue Zhao

Dr. Yue Zhao

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in Experimental Hematology & Oncology
Verified
Journal Article
Open access
PDF file
MCMinmin Cao
Minmin Cao
ZWZihao Wang
Zihao Wang
WLWanying Lan
Wanying Lan
BXBinghua Xiang
Binghua Xiang
WLWenjun Liao
Wenjun Liao
YZYue Zhao
Yue Zhao
As integral components of the immune microenvironment, tissue resident macrophages (TRMs) represent a self-renewing and long-lived cell population that plays crucial roles in maintaining homeostasis, promoting tissue remodeling after damage, defending against inflammation and even orchestrating cancer progression. However, the exact functions and roles of TRMs in cancer are not yet well understood. TRMs exhibit either pro-tumorigenic or anti-tumorigenic effects by engaging in phagocytosis and secreting diverse cytokines, chemokines, and growth factors to modulate the adaptive immune system. The life-span, turnover kinetics and monocyte replenishment of TRMs vary among different organs, adding to the complexity and controversial findings in TRMs studies. Considering the complexity of tissue associated macrophage origin, macrophages targeting strategy of each ontogeny should be carefully evaluated. Consequently, acquiring a comprehensive understanding of TRMs' origin, function, homeostasis, characteristics, and their roles in cancer for each specific organ holds significant research value. In this review, we aim to provide an outline of homeostasis and characteristics of resident macrophages in the lung, liver, brain, skin and intestinal, as well as their roles in modulating primary and metastatic cancer, which may inform and serve the future design of targeted therapies.

31 March 2025 in Theranostics
Verified
Journal Article
Open access
PDF file
XTXuerui Tao
Xuerui Tao
YWYiling Wang
Yiling Wang
BXBinghua Xiang
Binghua Xiang
DHDongmei Hu
Dongmei Hu
WXWei Xiong
Wei Xiong
YZYue Zhao
Yue Zhao
Significant sex disparities have been observed in cancer incidence, treatment response to immunotherapy, and susceptibility to adverse effects, affecting both reproductive and non-reproductive organ cancers. While lifestyle factors, carcinogenic exposure, and healthcare access contribute to these disparities, they do not fully explain the observed male-female variation in anti-tumor immunity. Despite the preferential expression of sex hormone receptors in immune cells, X chromosome also contains numerous genes involved in immune function, and its incomplete inactivation may enhance anti-tumor immune responses in females. In contrast, loss or downregulation of Y-linked genes in males has been associated with an increased cancer risk. Additionally, estrogen, progesterone and androgen signaling pathways influence both innate and adaptive immune responses, contributing to sex-specific outcomes in cancer progression and therapy. Sex-biased differences are also evident in the epigenetic regulation of gene expression, cellular senescence, microbiota composition, metabolism, and DNA damage response, all of which impact anti-tumor immunity and immunotherapy treatment efficacy. In general, the combination of sex chromosomes, sex hormones, and hormone receptors orchestrates the phenotype and function of various immune cells involved in tumor immunity. However, sex disparity in each specific immune cell are context and environment dependent, considering the preferential expression of hormone receptor in immune cell and sex hormone levels fluctuate significantly across different life stages. This review aims to outline the molecular, cellular, and epigenetic changes in T cells, B cells, NK cells, DCs, neutrophils, and macrophages driven by sex chromosomes and sex hormone signaling. These insights may inform the design of sex-specific targeted therapies and leading to more individualized cancer treatment strategies.

6 September 2025 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
RSRuitong Song
Ruitong Song
JLJiayao Li
Jiayao Li
QLQiuhan Liu
Qiuhan Liu
SYSen Yan
Sen Yan
HFHao Fu
Hao Fu
YZYue Zhao
Yue Zhao

24 May 2025 in Scientific Reports
Verified
Journal Article
Open access
XWXiaoxiao Wang
Xiaoxiao Wang
ZHZhenqiang He
Zhenqiang He
CLChongzhou Liao
Chongzhou Liao
PGPu Guo
Pu Guo
YZYue Zhao
Yue Zhao
WXWei Xiong
Wei Xiong
Despite previous studies, the association between screen-based sedentary behavior (SB) and erectile dysfunction (ED) remains unclear. This study aimed to investigate the relationship between screen-based SB and ED using data from the 2001–2004 National Health and Nutrition Examination Survey (NHANES). A total of 4,047 participants were included, of whom 1,192 (29.5%) had ED. Multivariable logistic regression models were used to analyze this association. After adjusting for potential confounders, screen-based SB exceeding 2 h per day was significantly associated with an increased risk of ED (OR = 1.32; 95% CI, 1.12–1.56; p < 0.0001). Subgroup analysis further confirmed a consistent and independent positive association across different population groups (all p for interaction > 0.05). These findings suggest a significant relationship between prolonged screen-based SB and ED in U.S. adult males. Further prospective studies are needed to confirm these results.

24 April 2026 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
XWXiyi Wang
Xiyi Wang
DHDongmei Hu
Dongmei Hu
RLRenqin Li
Renqin Li
WLWenjun Liao
Wenjun Liao
CLChao Li
Chao Li
YZYue Zhao
Yue Zhao
Epstein-Barr virus (EBV) is associated with a wide spectrum of lymphoid and epithelial malignancies. This review provides a comprehensive pan-tumor perspective on the convergent oncogenic mechanisms, immune microenvironment characteristics, and shared therapeutic vulnerabilities across EBV-related cancers. We systematically summarize EBV infection and latency patterns, highlighting key shared signaling networks (e.g., NF-κB, PI3K/AKT) alongside nuanced immune evasion strategies, such as HLA modulation and steric immune blockade. By bridging these molecular insights with clinical translation, we evaluate emerging therapeutic paradigms, including immune checkpoint inhibitors, EBV-specific T-cell therapies, neutralizing antibodies, and mRNA vaccines. Ultimately, this synthesis underscores the potential of exploiting shared viral vulnerabilities to develop pan-tumor targeted therapies, offering a strategic roadmap for future clinical development.

6 November 2025 in Journal of Colloid and Interface Science
Verified
Journal Article
Closed access
RSRuitong Song
Ruitong Song
SYSen Yan
Sen Yan
SLShunju Liu
Shunju Liu
QLQiuhan Liu
Qiuhan Liu
JLJiayao Li
Jiayao Li
HFHao Fu
Hao Fu